Show simple item record

A phase 1 study exploring the safety and tolerability of the small molecule Pd-L1 inhibitor, Incb086550, in patients with select advanced tumorss

dc.contributor.authorLe Tourneau, C.
dc.contributor.authorPiha-Paul, S.
dc.contributor.authorPrenen, H.
dc.contributor.authorDelafontaine, B.
dc.contributor.authorPinato, D.
dc.contributor.authorSantoro, A.
dc.contributor.authorKristeleit, R.
dc.contributor.authorSpencer, K.
dc.contributor.authorGangadhar, T.
dc.contributor.authorBurris, H.
dc.contributor.authorKotecki, N.
dc.contributor.authorBasu, B.
dc.contributor.authorGraham, Donna
dc.contributor.authorDi Giacomo, A. M.
dc.contributor.authorSahebjam, S.
dc.contributor.authorDi Nicola, M.
dc.contributor.authorGomez-Roca, C.
dc.contributor.authorTomasini, P.
dc.contributor.authorAscierto, P.
dc.contributor.authorCurigliano, G.
dc.contributor.authorKarasic, T.
dc.contributor.authorGeschwindt, R.
dc.contributor.authorDaniel, J.
dc.contributor.authorVan Cutsem, E.
dc.date.accessioned2023-05-17T09:50:55Z
dc.date.available2023-05-17T09:50:55Z
dc.date.issued2022en
dc.identifier.citationLe Tourneau C, Piha-Paul S, Prenen H, Delafontaine B, Pinato D, Santoro A, et al. A Phase 1 Study Exploring the Safety and Tolerability of the Small Molecule Pd-L1 Inhibitor, Incb086550, in Patients with Select Advanced Tumors. Journal for immunotherapy of cancer. 2022 Nov;10:A805-A. PubMed PMID: WOS:000919423400730.en
dc.identifier.doi10.1136/jitc-2022-SITC2022.0774en
dc.identifier.urihttp://hdl.handle.net/10541/626278
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1136/jitc-2022-SITC2022.0774en
dc.titleA phase 1 study exploring the safety and tolerability of the small molecule Pd-L1 inhibitor, Incb086550, in patients with select advanced tumorssen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentInstitut Curie, Paris, France;en
dc.identifier.journalJournal for Immunotherapy of Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record